It is my great pleasure to invite you to a symposium that not only exemplifies modern biomarker research but also enables us to compete in this emerging field of clinical neuroscience. In spring of 2019 we established a state-of-the-art single molecular analyzer (SIMOA), which allows for reliable quantification of proteins at an ultra-low concentration. This technology now offers the opportunity to engage more deeply in the emerging implications and demands of personalized medicine.
On 3rd December we are looking forward to giving you an overview of recent and potentially ground-breaking biomarker research in translational and clinical neuroscience. You may learn how biomarker studies are just the beginning of a multi-tiered approach that, in the best case, leads to relevant applications in clinical routine practice. We hope to spur your interest for this exciting innovation and picture new ways for interdisciplinary cutting edge biomarker research.
With my best wishes,
Department of Neurology
Die Teilnahme ist kostenlos, eine Anmeldung nicht erforderlich.
Dr. Patrick Altmann
Universitätsklinik für Neurologie
Medizinische Universität Wien
Tel. (Sekretariat): 01/40400 31450